The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: <i>Actionable Perspectives</i>
Insulin receptor overexpression is a common event in human cancer. Its overexpression is associated with a relative increase in the expression of its isoform A (IR<b><sup>A</sup></b>), a shorter variant lacking 11 aa in the extracellular domain, conferring high affinity for t...
Main Authors: | Pierluigi Scalia, Antonio Giordano, Stephen J. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/2/366 |
Similar Items
-
IGF-IR targeted therapy: past, present and future
by: Joseph A.M.J.L. Janssen, et al.
Published: (2014-12-01) -
Understanding IGF-II Action through Insights into Receptor Binding and Activation
by: Andrew J. Blyth, et al.
Published: (2020-10-01) -
Insulin Receptor Isoforms in Cancer
by: Veronica Vella, et al.
Published: (2018-11-01) -
EXPRESSION OF IGFBP-6 IN COLORECTAL CANCER: THE RELATION WITH INSULIN-LIKE GROWTH FACTOR RECEPTOR, ADIPONECTIN LEVEL AND ITS RECEPTORS
by: N. V. Yunusova, et al.
Published: (2015-12-01) -
New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations
by: Joseph A.M.J.L. Janssen
Published: (2020-04-01)